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Bidirectional rescue of extreme genetic predispositions to
anxiety: impact of CRH receptor 1 as epigenetic plasticity gene
in the amygdala
SV Sotnikov1,2,4, PO Markt1,4, V Malik1, NY Chekmareva2, RR Naik1, A Sah3, N Singewald3, F Holsboer1, L Czibere1 and R Landgraf1
The continuum of physiological anxiety up to psychopathology is not merely dependent on genes, but is orchestrated by the
interplay of genetic predisposition, gene x environment and epigenetic interactions. Accordingly, inborn anxiety is considered a
polygenic, multifactorial trait, likely to be shaped by environmentally driven plasticity at the genomic level. We here took advantage
of the extreme genetic predisposition of the selectively bred high (HAB) and low anxiety (LAB) mouse model exhibiting high vs low
anxiety-related behavior and tested whether and how beneﬁcial (enriched environment) vs detrimental (chronic mild stress)
environmental manipulations are capable of rescuing phenotypes from both ends of the anxiety continuum. We provide evidence
that (i) even inborn and seemingly rigid behavioral and neuroendocrine phenotypes can bidirectionally be rescued by appropriate
environmental stimuli, (ii) corticotropin-releasing hormone receptor 1 (Crhr1), critically involved in trait anxiety, shows bidirectional
alterations in its expression in the basolateral amygdala (BLA) upon environmental stimulation, (iii) these alterations are linked to an
increased methylation status of its promoter and, ﬁnally, (iv) binding of the transcription factor Yin Yang 1 (YY1) to the Crhr1
promoter contributes to its gene expression in a methylation-sensitive manner. Thus, Crhr1 in the BLA is critically involved as
plasticity gene in the bidirectional epigenetic rescue of extremes in trait anxiety.
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INTRODUCTION
Inborn anxiety is considered a polygenic, multifactorial trait whose
continuum of physiological anxiety up to psychopathology is likely
to be shaped by environmentally driven plasticity at the genomic
level.1 Epigenetic processes are capable of integrating environ-
mental signals into the genome2,3 and indeed interact with the
genetic predisposition of an individual,4 thereby creating a new
category of disease etiology. Epigenetic mechanisms contribute to
pathological alterations in brain regions important for the
regulation of anxiety inter alia by adding5 or removing2 methyl
groups at CpG dinucleotides within regions denoted as CpG
islands (CGi). The concept of plasticity genes6 emphasizes that a
promising candidate should (i) be amenable to both beneﬁcial
and detrimental environmental inﬂuences and (ii) reﬂects the
interplay of genetic load and epigenetic processes in the
regulation of anxiety along the continuum. Plasticity genes thus
represent promising candidates to elucidate how epigenetic
processes might shape a (seemingly) rigid genetic predisposition
in the development of pathological anxiety—a scenario that has
largely been neglected so far.
We here took advantage of a mouse model of extremes in trait
anxiety and tested whether environmental manipulation is
capable of bidirectionally rescuing the genetically driven anxiety
phenotype via epigenetic mechanisms. After >45 generations of
selective inbreeding, HAB mice are supposed to accumulate risk
factors of pathological anxiety, thus resembling genetically
predisposed psychiatric patients.7 Inbred LAB mice represent the
other end of the phenotypic continuum. Environmental manip-
ulations such as enriched environment (EE)—a combination of
biologically relevant inanimate and social stimuli—and chronic
mild stress (CMS) are promising tools to induce anxiolytic and
anxiogenic effects, respectively, thereby shifting the anxiety
phenotype of HAB and LAB mice bidirectionally toward ‘normal’.
Recently, we have shown that differences in amygdala activity is
a mechanism behind shifts in anxiety-related behavior after EE
and CMS.8 Crhr1, which is one of the most important mediators of
amygdala activity, is a candidate plasticity gene that possibly
contributes or even underlies such environmentally driven
behavioral and electrophysiological changes in the HAB/LAB
model. Both the amygdala and the corticotrophin-releasing
hormone system are well known to be involved in the regulation
of behavioral and neuroendocrine correlates of anxiety.9,10
We therefore aimed at testing whether even an extreme genetic
predisposition toward high (HAB) or low (LAB) trait anxiety may be
rescued toward ‘normal’ anxiety by applying either EE or CMS
(Figure 1a). If so, does this bidirectional rescue involves Crhr1 as a
plasticity gene of anxiety whose differential expression proﬁles
might be explained by epigenetic phenomena? Based on compre-
hensive phenotyping, we succeeded in identifying molecular–-
genetic mechanisms underlying the bidirectional epigenetic
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rescue of genetically predisposed anxiety, including methylation
of the Crhr1 promoter and the epigenetic transcription factor YY1.
MATERIALS AND METHODS
Animals
Mice were selectively inbred from a CD-1 outbred population for high,
‘normal’ (NAB) or low anxiety-related behavior for >45 generations, with
percent time spent on open arms as key criterion (HAB o15%, NAB
35–45%, LAB >60%). They were kept under standard housing conditions
and were provided with food and water ad libitum (details see in
Supplementary Information).
EE and CMS
EE was applied to HAB mice and comprised two periods: from postnatal
days 15–28, pups and their respective dam were transferred for 6 h per day
to EE, whereas from postnatal days 28 pups were weaned, arranged in
groups of three and transferred to EE permanently until postnatal days 42.
CMS was applied to LAB mice exactly at the same time period as EE and
comprised a series of alternating mild stressors such as maternal
separation, restrained stress, overcrowding and others. Detailed informa-
tion on EE and CMS is described in the Supplementary Materials
(Supplementary Information).
Anxiety-related behavior
To measure anxiety-related behavior, animals were tested in the open
ﬁeld, elevated plus-maze and light–dark (LD) box . For more details see
Supplementary Information.
Home cage locomotion
Home cage activity was quantiﬁed via an automated system (Inframot; TSE,
Bad Homburg, Germany) over a period of two light cycles and three dark
cycles (details see in Supplementary Information).
HPA axis reactivity test (HPA-RT)
HPA axis reactivity, that is, increase of blood corticosterone (CORT) after
stress, of HABs was evaluated by exposure to 15min restraint stress. Five-
minute forced swimming instead of immobilization stress was used as a
stressor for LABs, since the former had regularly been used throughout the
Figure 1. Conceptual framework and behavioral effects of environmental modiﬁcations. The triangle reﬂects the anxiety continuum with HAB
and LAB representing its extremes and HAB-EE and LAB-chronic mild stress (CMS) the environmentally driven shifts toward ‘normal’ (a).
‘Normal’ anxiety (dashed line) indicates behavior of normal anxiety-related behavior mice (NAB), bred in parallel with LAB and HAB mice, with
percent time spent on the open arms of the elevated plus-maze in the 35–45% range. Enriched environment (EE) signiﬁcantly decreased and
CMS increased percent time spent in the light compartment of the light–dark (LD) box (b) and open arms of the elevated plus maze (c)
(n= 8–12 animals per group). High and low anxiety after environmental manipulations is not associated with decreased or increased home
cage locomotion after EE (d) or CMS (e) (n= 8 animals per group). Bars represent mean+s.e.m. *Po0.05, **Po0.01 (MWU).
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CMS procedure. Blood CORT was compared before and after HPA-RT
(details see in Supplementary Information).
Radio immunoassay
Ten microliters of plasma were used to determine the concentration of
CORT via a RIA kit from MP Biomedicals (Solon, Ohio, USA) according to the
manufacturer’s instructions (details see in Supplementary Information).
Bilateral application of a CRHR1 antagonist
Male mice were ﬁxed into a stereotaxic apparatus and anesthetized with
an oxygen/Forene mixture. A guide cannula was implanted bilaterally in
the basolateral amygdala (BLA) and ﬁxed. Animals were injected three
times within an interval of 36 h either with 2 μl of CRHR1 antagonist (α-
helical CRF 9–41, Sigma-Aldrich, Hamburg, Germany) or vehicle (Ringer’s
solution). To assess anxiety-related behavior, tests were conducted 40min
after injections (details see in Supplementary Information).
Quantitative real-time PCR (qPCR)
Total RNA was extracted from tissue punches collected from BLA or from
mouse-neuro-2a (N2a) cells as previously described.11 RNA was reverse
transcribed to cDNA using the high-capacity cDNA reverse transcription kit
(Applied Biosystems, Foster City, CA, USA). Expression of Crhr1 and YY1 was
performed using QuantiFast SYBR Green PCR Kit (Qiagen). All samples were
analyzed in duplicates and normalized to the housekeeping genes: Polr2b,
B2mg and Rpl13a (details see in Supplementary Information).
Identiﬁcation of CGi, primer design and pyrosequencing
The CGi of Crhr1 was identiﬁed utilizing CpG Island Searcher (default
settings, release 29.10.04). DNA for pyrosequencing was extracted from the
other half of tissue punch or N2a cells lysate and processed by Varionostic
(Ulm, Germany), which performed primer design and pyrosequencing
(details see in Supplementary Information).
Construction of a promoter-luciferase reporter
Phusion DNA polymerase (New England Biolabs, Frankfurt, Germany) was
used to generate a 1786 bp promoter part from LAB genomic DNA, which
had been inserted between the SpeI and HindIII sites of a pCpG-free
luciferase vector (provided by M. Rehli, University Hospital Regensburg,
Germany). The plasmid carrying murine YY1 cDNA was purchased from the
DNA Resource CORE (Clone ID: MmCD00311470). All plasmids were
sequenced before the reporter assays (details see in Supplementary
Information).
In vitro methylation of DNA
Site-speciﬁc methylation was performed according to Martinowich et al.12
Modiﬁed oligonucleotides were purchased from Sigma-Aldrich. Complete
methylation of the Crhr1 promoter was performed using SssI methylase
(New England Biolabs) according to the supplier’s instructions; a mock-
methylated plasmid was treated in the absence of S-adenosylmethionine.
Products were bisulﬁte converted (EpiTech Bisulﬁte Kit, Qiagen, Hilden,
Germany) and sequenced to control their respective methylation status
(details see in Supplementary Information).
Cell culture, transfection and reporter gene assay
N2a cells were cultured under standard conditions. Cells were plated in 96
well plates, transfected either with a methylated or unmethylated plasmid
and pCMV-Gaussia vector as an internal control using Turbofect
Transfection reagent (Thermoscientiﬁc, Braunschweig, Germany). Cells
were lysed after 40 h. Fireﬂy and gaussia luciferase activities were
measured as described by Schulke et al.13 To evaluate if YY1 exhibits a
regulatory role on the Crhr1 promoter, a control vector (SPORT6) or a
vector expressing YY1 cDNA (YY1) was co-transfected with plasmids
carrying the Crhr1 promoter and pCMV-Gaussia. The same approach was
used to overexpress YY1 in the presence of plasmids with modiﬁed
methylation (more detailed see in Supplementary Information).
Western blotting
To verify that transfection with plasmid carrying YY1 cDNA indeed induced
a higher amount of YY1 protein, the nuclear fraction was extracted from
transfected cells. Total protein amounts were measured in a BSA assay
(Pierce BCA Protein Assay Kit, Thermoscientiﬁc, Braunschweig, Germany).
Assessment of YY1 protein was performed via Western Blot using an anti-
YY1 antibody (sc-1703, Santa Cruz Biotechnology, Heidelberg, Germany)
(details see in Supplementary Information).
Immunoﬂuorescent assay
To further visualize an increase in the amount of YY1 protein in transfected
cells, plasmid carrying YY1 cDNA was co-transfected with GFP. Cells were
mounted on cover slips, transfected, ﬁxed with 4% paraformaldehyde and
incubated overnight with anti-YY1 antibody (sc-1703, Santa Cruz
Biotechnology). Next day, cover slips were washed and stained with
secondary antibody (ALEXA Fluor 594, Lifetechnologies, Darmstadt,
Germany), followed by a 4',6-diamidino-2-phenylindole solution and ﬁnally
analyzed by ﬂuorescent microscopy (details see in Supplementary
Information).
Electrophoretic mobility shift assay
EMSA probes were end-labeled with 32P-dCTP (PerkinElmer, Rodgau,
Germany). For the EMSA reaction, nuclear extracts from N2a cells were
incubated for 5 min in binding buffer. labeled fragments were diluted to
20 000 c.p.m., thereof 1 μl was added to the EMSA reaction. Samples were
electrophoresed on 6% polyacrylamide gel. Antibodies and a competitor
for the shift assay were supplied 30min before adding labeled
oligonucleotides. To check the impact of CpG1 methylation on YY1
binding afﬁnity, a plasmid carrying the Crhr1 promoter fragment was
incubated with SssI methylase as described before. Gels were exposed to
radiation-sensitive ﬁlms (Kodak Biomax MR ﬁlms, Eastman Kodak,
Rochester, NY, USA) for 2 days (for details see Supplementary Information).
Statistics
Data were analyzed using either ANOVA (one-way, two-way or two-way
with repeated measures, as appropriate) followed by Tukey’s post hoc test.
Comparisons of two independent groups were analyzed by Mann–Whitney
U test. Statistical signiﬁcance was achieved at Po0.05 (for details see
Supplementary Information).
RESULTS
Bidirectional rescue of extreme trait anxiety
EE exhibited a signiﬁcant anxiolytic and CMS an anxiogenic effect
in HAB and LAB mice, respectively (Figure 1b and c). While EE
signiﬁcantly increased percent time spent on the open arms of the
elevated plus maze (Po0.01) and in the light compartment of the
LD (Po0.05), CMS signiﬁcantly decreased the same parameters
(Po0.01 for both elevated plus maze and LD).
Repeated measures ANOVA revealed that EE or CMS did not
affect locomotion in the home cage of HABs (F(1,59) = 0.32, P= 0.58)
and LABs (F(1,59) = 0.87, P= 0.37), respectively (Figure 1d and e).
HPA axis reactivity is associated with anxiety-related behavior
We utilized HPA-RT to reveal whether stress-induced CORT release
is associated with the bidirectional shift of anxiety-related
behavior. Indeed, ANOVA revealed an association between
housing and CORT release (F(1,31) = 7.40, Po0.01 for HAB and
F(1,41) = 45.5, Po0.001 for LAB; Figure 2a). The EE-induced
decrease and CMS-induced increase in the CORT response to
stressor exposure suggest that not only the behavioral but also
the neuroendocrine phenotype could be shifted in a bidirectional
manner.
Crhr1 in the amygdala modulates anxiety-related behavior
Earlier it was shown that anxiety-related behavior is associated
with Crhr1 expression in the amygdala.8 We analyzed Crhr1 mRNA
levels within the BLA by qPCR and, indeed, observed both a
difference between HAB and LAB as well as a bidirectional
modulation of gene expression dependent on the environmental
manipulation used. HABs exhibited an overexpression of Crhr1 in
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comparison to LABs (Po0.05), which could be shifted bidir-
ectionally with EE signiﬁcantly decreasing (Po0.05) and CMS
signiﬁcantly increasing Crhr1 mRNA levels (Po0.05; Figure 2b).
Importantly, no changes were observed in the expression of Crh,
thereby minimizing the possibility of masking effects of the ligand.
Next, we injected the CRHR1 antagonist α-helical CRH(9-41)
(Sigma-Aldrich) bilaterally into the BLA of HABs to verify the
CRHR1 contribution to anxiety-related behavior (Figure 2c).
Indeed, administration of the antagonist entailed an anxiolytic
effect apparent as increase of percent time spent in the inner zone
of the OF (Po0.05; Figure 2d).
CpG1 methylation of Crhr1 promoter suggests a critical role for
epigenetic regulation
Assuming an epigenetic mechanism in the regulation of Crhr1, we
performed in silico analyzes and identiﬁed a CGi in the promoter
region of HAB and LAB mice (CpG island searcher), which was
subsequently pyrosequenced (Figure 3a). We identiﬁed a differ-
entially methylated region (DMR) 1348 bp upstream of the
translation start site with both EE (n= 4 HAB, HAB-EE, Po0.05)
and CMS (n= 4 LAB, LAB-CMS, Po0.05) signiﬁcantly increasing
methylation at the CpG1 site (Figure 3e). In silico analysis (Ensembl,
NCBIM37) based on whole genome bisulﬁte sequencing of two
cell lines—embryonic stem cells and nasopharyngeal carcinoma
cells—also revealed different methylation patterns at that position
(≈50 and 100% methylation, respectively) (Figure 3b), suggesting
a critical role of CpG1 for epigenetic regulation. A subsequent
luciferase assay conﬁrmed that methylation of the identiﬁed DMR
indeed had an impact on promoter activity, since methylation
induced a signiﬁcant reduction of luciferase activity compared to
the unmethylated plasmid (Po0.05; Figure 3f). Complete
methylation of the plasmid using SssI methylase caused compar-
able silencing of the reporter gene (Po0.01; Figure 3f).
Transcription factor YY1 regulates Crhr1 expression in a
methylation-dependent manner
Further in silico analyzes (JASPAR CORE vertebrata database)
demonstrated that the transcription factor YY1 can bind adjacent
to the identiﬁed DMR (Figure 3c). Indeed, our EMSA experiments
conﬁrmed the ability of YY1 to bind at the predicted position
(Figure 3d); YY1 overexpression (lanes 2–3) as well as higher
protein input (lanes 7–9) increased band intensity, whereas
addition of unlabeled probe in excess (competitor) or YY1-
speciﬁc antibody (YY1 AB), but not unspeciﬁc (US AB), prevented
band appearance (lanes 4–6). These data indicated that the
amount of YY1 was important for the regulation of gene activity.
Importantly, YY1 expression was found modulated bidirectionally
with EE decreasing and CMS increasing (Po0.05 both) YY1 mRNA
levels in the BLA of HAB and LAB mice, respectively (Figure 4a). To
further test whether YY1 is able to regulate Crhr1 expression, we
transfected N2a cells with a plasmid carrying YY1 cDNA, resulting
in a higher accumulation of YY1 (Po0.001; Figure 4b and c),
similar to CMS exposure (Figure 4a). Indeed, overexpression of the
transcription factor induced higher expression of Crhr1 mRNA
(Po0.05; Figure 4d). Kim et al.14 found that the amount of YY1 is
important for de novo methylation of DNA sequence around its
binding sites. Thus, we evaluated the methylation of CpG1 after
YY1 overexpression and found no difference between mock and
YY1 cDNA transfected cells (Figure 4e) indicating that methylation
could be a primary event potentially affecting the binding ability
of YY1. We tested this hypothesis by using methylated and non-
methylated probes for EMSA and indeed we succeeded in
showing that methylation of CpG1 decreased the binding ability
of YY1 (Po0.05; Figure 5a). At the functional level, using luciferase
assay, YY1 overexpression strongly enhanced Crhr1 promoter
activity (Po0.001), whereas activity of the methylated plasmid
was signiﬁcantly lower (Po0.05; Figure 5b).
Figure 2. Effects of environmental modiﬁcations on stress-induced
CORT realease and involvement of Crhr1 in the regulation of anxiety.
Enriched environment (EE)–induced anxiolysis is associated with a
signiﬁcantly reduced (analysis of variance) corticosterone (CORT)
response to stressor exposure (reactive CORT); in contrast, chronic
mild stress (CMS) caused an anxiogenic effect associated with an
increased CORT response (a). Crhr1 in the basolateral amygdala (BLA)
contributes to anxiety-related behavior; it is overexpressed in HAB
compared to LAB mice (MWU), whereas EE and CMS are capable of
bidirectionally shifting messenger RNA levels (b) (n= 6-7 per group).
Bilateral application of a CRHR1 antagonist into BLA. Schematic
illustration of the sites of BLA hits for animals used in CRHR1
antagonist group (black dots) and vehicle group (red dots) (c).
Antagonist treatment signiﬁcantly reduced (MWU) anxiety-related
behavior of HABs in the open ﬁeld test (d). Bars represent mean+
s.e.m. n= 6–7 per group. *Po0.05, **Po0.01, ***Po0.001.
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DISCUSSION
Pathological anxiety originates from a complex interplay of
genetic predisposition, environmental and epigenetic processes,1
highlighting the necessity to identify epigenetic processes that
alleviate or even rescue a detrimental genetic predisposition. In
the present study, we provide evidence that environmental
manipulations indeed can bidirectionally shift the extreme genetic
predispositions to high (HAB) and low (LAB) anxiety along the
anxiety continuum toward ‘normal’ by epigenetic regulation of the
Crhr1 promoter in the BLA.
EE has repeatedly proven its anxiolytic effects,9,15 contrary to
CMS that promotes anxiety-related16,17 and depression-like18
behaviors. We here conﬁrm and extend these effects by illustra-
ting that EE increased (HAB) and CMS decreased (LAB) percent
time spent in the light compartment of the LD and on open arms
Figure 3. The relations of promoter methylation and YY1 to Crhr1. Methylation of 186 single CpG sites of the Crhr1 promoter has been
analyzed in the basolateral amygdala (BLA) of CD-1 mice (a). In silico analysis predicts CpG1 to be a differentially methylated region (DMR).
Prediction is based on data from whole genome bisulﬁte sequencing of embryonic stem cells (ES) and neuronal primary cells (NPC) (b).
Methylation-sensitive transcription factor YY1 was proposed to bind close to the DMR, thereby modulating gene expression (c).
Electrophoretic mobility shift assay (d) conﬁrmed binding of YY1 in the proximity to CpG1 of Crhr1: (i) YY1 overexpression increased band
intensity (lanes 1–3), (ii) incubation with speciﬁc YY1-antibody, but not with unspeciﬁc antibody, prevented band formation (lanes 4–5), (iii)
addition of unlabeled probe in excess (competitor) prevents band formation (lane 6), and (iv) increased amount of protein input induced
higher band intensity (lanes 7–9). Both environmental manipulations (enriched environment (EE) and chronic mild stress (CMS)) signiﬁcantly
increased methylation of a CpG site within the Crhr1 promoter; for details see text (e). Complete methylation of the Crhr1 promoter (pCrhr1
SssI) further decreases its activity as indicated by the luciferase assay; however, speciﬁc methylation of only CpG1 (pCrhr1 mCpG1) is already
sufﬁcient for reducing promoter activity (f). Bars represent mean+s.e.m. *Po0.05, **Po0.01 (MWU).
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of the elevated plus maze (Figure 1a and b). Importantly, the
environmentally driven shifts in anxiety are not masked by
locomotion, as spontaneous activity in the home cage was not
affected, neither by EE or by CMS (Figure 1d and e). Moreover, we
could show that HPA axis reactivity is associated with anxiety-
related behavior (Figure 2a). Thus, even robust behavioral and
neuroendocrine phenotypes driven by a (seemingly) rigid genetic
predisposition can be shifted bidirectionally by environmental
manipulations depending on the respective type used. This is
particularly striking in male HAB mice that turned out to be non-
responsive even to anti-depressive/anxiolytic medication in
adulthood.19 It is important to note here that, according to the
mismatch hypothesis,20,21 exposure of LAB mice to EE and HAB
mice to CMS can potentially lead to similar behavioral outcomes
due to changes in their stress-sensitivity. Although our experi-
ments did not support this suggestion (data not shown), the
mismatch approach can be another hypothetical way of
manipulating the phenotype of HAB and LAB mice, respectively.
Human studies indicate that amygdala activation positively
correlates with the degree of trait anxiety.22 Our recent experi-
ments also found higher amygdala activity in HAB compared
with LAB mice, with changes in anxiety after EE and CMS followed
by corresponding shifts in amygdala activity.8 However,
the molecular mechanisms behind these phenomena are largely
unknown. Accordingly, Rogers et al.23 reported strong associ-
ations between anxiety-related behavior, amygdala activity and
Crhr1 in nonhuman primates. We here hypothesized that Crhr1
in the amygdala is critically involved as plasticity gene in the
bilateral behavioral shifts. Indeed, HABs compared with LABs
exhibited an overexpression of Crhr1 in the amygdala. Moreover,
the Crhr1 expression proﬁle could be shifted bidirectionally to the
better or the worse manner6 depending on the type of environ-
mental manipulation (Figure 2b). A causal relation between
anxiety and CRHR1 in the BLA was further established by bilateral
application of the CRHR1 antagonist α-helical CRH(9–41) leading to
signiﬁcant anxiolytic effects in HABs (Figure 2d). The antagonist
effect clearly suggests that alterations in expression have
the potential to contribute to the bilateral phenotypic shifts.
These data are in line with Sztainberg et al.9 who found reduced
expression of amygdalar Crhr1 as a mediator of anxiolytic
effects of EE.
Based on the expression data in HAB vs LAB mice and the
response to environmental manipulation, we further hypothesized
that DNA methylation exerts regulatory control over Crhr1 within
the BLA to integrate environmental stimuli into the genome to
adapt anxiety-related behavior to external demands. Previous
studies showed that adding5 or removing2 methyl groups at CpG
dinucleotides within regions denoted as CGis may silence or
stimulate transcription of genes thought to be involved in the
regulation of anxiety-related behavior. Therefore, we utilized
Figure 4. YY1 overexpression and effects on the CpG1 methylation. A bidirectional regulation of YY1 expression in the basolateral amygdala
(BLA) of HAB and LAB mice after enriched environment (EE) and chronic mild stress (CMS), respectively (a). Transfection of mouse-neuro-2a
(N2a) cells with a plasmid carrying YY1 cDNA increases YY1 expression as indicated by Western blot (b). Only cells transfected with YY1-
expressing plasmid (green staining) accumulated higher YY1 (red staining) as shown using immunoﬂuorescent microscopy (c). YY1
overexpression up-regulates Crhr1 messenger RNA (d), but does not alter methylation of CpG1 in the Crhr1 promoter (e). Bars represent mean
+s.e.m. *Po0.05, ***Po0.001 (MWU).
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pyrosequencing of bisulﬁte-treated DNA to assess methylation of
the Crhr1 CGi in vivo (Figure 3a). To our surprise, we identiﬁed that
both EE and CMS signiﬁcantly increased methylation at a CpG site
1348 bp (CpG1) upstream of the translational start site (Figure 3d).
Moreover, data from whole genome bisulﬁte sequencing
of embryonic stem cells (ES) and neuronal primary cells (NPC)
also suggest CpG1 as DMR (Figure 3b), highlighting an implication
of this site in epigenetic control. A subsequent luciferase assay
conﬁrmed that this DMR indeed exerted a regulatory role on Crhr1
promoter with methylation promoting a decrease in activity
(Figure 3f). To further elucidate this unidirectional increase in
CpG1 methylation after EE and CMS, we performed an in silico
analysis and identiﬁed the epigenetic transcription factor YY1,
which binds adjacent to the DMR (Figure 3c). Surprisingly, YY1 is
bidirectionally modulated with HAB-EE mice exhibiting lower and
LAB-CMS mice higher expression compared with corresponding
controls (Figure 4a). In vitro overexpression of YY1 positively
regulated Crhr1 (Figure 4d), thus suggesting that higher expres-
sion of YY1 in vivo after CMS mediates higher expression of Crhr1.
The opposite effect could be true for HAB-EE mice expressing less
of this transcription factor. Interestingly, Kim et al.24 found YY1 to
have an important role in de novo methylation of CpGs around its
binding sites during genomic imprinting. We did not observe a
change in methylation of Crhr1 CpG1 after YY1 overexpression
(Figure 4e), suggesting another mechanism of regulation of this
epigenetic mark in response to external environmental inﬂuences.
The unidirectional increase in CpG1 methylation after EE and CMS
seems to be a paradox; however, our data provide evidence of an
importance of CpG1 methylation for YY1-induced regulation of
Crhr1 expression. The presence of methylation in the DMR affects
transcription factor and DNA interaction, as indicated by weaker
binding in EMSA (Figure 5a) and less activation of the complete
and site-speciﬁc methylated (CpG1) promoters compared with the
unmethylated control in the presence of YY1 (Figure 5b). These
data are consistent with studies indicating a methylation-sensitive
mechanism of YY1 interaction.24,25 Thus, methylation can facilitate
(i) downregulation of Crhr1 expression when YY1 is lacking (for
example, HAB-EE) and, in turn, (ii) ﬁne-tune an expression
enhancement when YY1 is upregulated (for example, LAB-CMS).
Supporting and extending the concept of plasticity genes,6 we
suggest that Crhr1 is the ﬁrst identiﬁed plasticity gene of anxiety
which (i) is critically involved in the regulation of behavioral and
neuroendocrine phenotypes by epigenetic mechanisms and (ii)
may be regulated bidirectionally, depending on the type of
environmental stimuli. This plasticity may epigenetically rescue
extremes in anxiety-related behavior from both ends of the
anxiety continuum. The CpG1 site has thus the potential to be
used as a biomarker for ‘normalization’ of extreme anxiety-related
behavior and highlights the role of transcription factor YY1 in the
epigenetic regulation of Crhr1 expression. It is plausible that the
bidirectionality, as described here, gives rise to subtle and ﬂexible
regulation of anxiety-related behavior. Future experiments using
whole genome assays will reveal plastic candidate genes in
addition to Crhr1.
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